Rosai-Dorfman disease: FDG PET/CT findings in a patient presenting with pyrexia and cervical adenopathy

Clinical Nuclear Medicine

Volumn 35, Issue 8, 2010, Pages 576-578

  Hock, Andrew Tan Eik ^a   Long, Mark Tan Ming ^b   Sittampalam, Kesavan ^a   Eng, David Ng Chee ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

cervical adenopathy; FDG PET CT; histiocytosis; Rosai Dorfman

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHINESE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; FEVER; HUMAN; ROSAI DORFMAN DISEASE; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; LYMPHATIC SYSTEM DISEASE; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; SINUS HISTIOCYTOSIS; YOUNG ADULT;

FEMALE; FEVER; FLUORODEOXYGLUCOSE F18; HISTIOCYTOSIS, SINUS; HUMANS; LYMPHATIC DISEASES; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77955124680     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181e4de80     Document Type: Article

References (11)

1. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol (Chicago). 1969;87:63-70.
2. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 Cases. Cancer. 1972; 30:1174-1188.
3. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman Disease): review of the entity. Semin Diagn Pathol. 1990;7:19-73. (Pubitemid 20075700)
4. Bazemore AW, Smucker DR. Lymphadenopathy and malignancy. Am Fam Physician. 2002;66:2103-2110.
5. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007;25:571-578.
6. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579-586.
7. Menzel C, Hamscho N, Döbert N, et al. PET imaging of Rosai-Dorfman disease: correlation with histopathology and ex-vivo beta-imaging. Arch Dermatol Res. 2003;295:280-283.
8. Yu JQ, Zhuang H, Xiu Y, et al. Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography. Clin Nucl Med. 2004;29:209-210.
9. Lim R, Wittram C, Ferry JA, et al. FDG PET of Rosai-Dorfman Disease of the thymus. Am J Roentgenol. 2004;182:514.
10. Foucar E, Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. An analysis of 14 deaths occurring in a patient registry. Cancer. 1984;54:1834-1840.
11. Pulsoni A, Anghel G, Falcucci P, et al. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol. 2002;69:67-71.